Action DC4 DEXCOM, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Communiqués DexCom, Inc. Deutsche Boerse AG

Actions

DC4

US2521311074

Marché Fermé - Deutsche Boerse AG
Autres places de cotation
 08:20:02 25/06/2024 		Varia. 5j. Varia. 1 janv.
102,8 EUR -5,36% Graphique intraday de DexCom, Inc. -5,15% -8,22%
25/06 Badaboum Our Logo
20/06 Glucotrack annonce la nomination d'Andy Balo au conseil d'administration CI

Communiqués

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Dexcom Expands AID Partnership Into The Netherlands
BU
Dexcom Showcases Extensive Clinical Data at ADA 2024 Demonstrating the Benefit of Dexcom CGM Use Among People With Type 2 Diabetes
BU
DexCom : William Blair 44th Annual Growth Stock Conference
PU
Dexcom G7 Now Connects Directly to Apple Watch in the U.S.
BU
Dexcom Wins Access to Dexcom ONE for 100,000 People Living With Type 2 Diabetes
BU
Nova Scotia Now Providing Coverage for Dexcom Continuous Glucose Monitoring Systems
BU
Dexcom Announces Upcoming Conference Presentation
BU
Dexcom Launches Innovative New Sensor as Groundbreaking Report Reveals Alarming Rates of Anxiety and Depression in Those With Type 2 Diabetes
BU
DexCom : Human Rights Statement
PU
DexCom: Q1 Earnings Snapshot
AQ
Dexcom Reports First Quarter 2024 Financial Results
BU
Dexcom Publishes Annual Sustainability Report
BU
Dexcom Schedules First Quarter 2024 Earnings Release and Conference Call for April 25, 2024 at 4:30 p.m. Eastern Time
BU
Unlocking UPC Secrets: No Standardisation Of Penalties For Confidentiality Breaches Across Local Divisions
AQ
DexCom : Raymond James Institutional Investors Conference
PU
Stelo by Dexcom First Glucose Biosensor to be Cleared by FDA as Over-the-Counter
BU
Dexcom Showcases Leadership in AID and Power of Dexcom CGM in Type 2 Diabetes With New Data at ATTD
BU
Dexcom Announces Upcoming Conference Presentation
BU
DexCom: Q4 Earnings Snapshot
AQ
Dexcom Reports Fourth Quarter and Fiscal Year 2023 Financial Results
BU
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action DXCM
  4. Action DC4
  5. Actualités DexCom, Inc.
  6. Communiqués